Is CYYNF or DIVO a better dividend investment in 2026?

CYYNF currently yields 909.09% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: CYYNF offers higher current income.

What is the dividend yield difference between CYYNF and DIVO?

CYYNF has a forward dividend yield of 909.09% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 902.60 percentage points.

Home › Compare › CYYNF vs DIVO

CYYNF vs DIVO: Dividend Comparison 2026

CYYNF yields 909.09% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CYYNF wins by $8252648.18M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CYYNF

● Live price

909.09%

Share price

$0.22

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8252648.21M

Annual income

$6,784,560,004,057.53

Full CYYNF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — CYYNF vs DIVO

📍 CYYNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CYYNF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CYYNF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CYYNF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYYNF

Annual income on $10K today (after 15% tax)

$77,272.73/yr

After 10yr DRIP, annual income (after tax)

$5,766,876,003,448.90/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, CYYNF beats the other by $5,766,876,002,614.47/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYYNF + DIVO for your $10,000?

CYYNF: 50%DIVO: 50%

100% DIVO50/50100% CYYNF

Portfolio after 10yr

$4126324.12M

Annual income

$3,392,280,002,519.61/yr

Blended yield

82.21%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYYNF buys

DIVO buys

No recent congressional trades found for CYYNF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCYYNFDIVO

Forward yield	909.09% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$8252648.21M ✓	$30.7K
Annual income after 10y	$6,784,560,004,057.53 ✓	$981.68
Total dividends collected	$8138900.96M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CYYNF vs DIVO ($10,000, DRIP)

Year	CYYNF Portfolio	CYYNF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$101,609	$90,909.09	$11,349	$649.42	+$90.3K → CYYNF
2	$972,011	$863,288.79	$12,833	$688.83	+$959.2K → CYYNF
3	$8,758,157	$7,718,105.75	$14,459	$727.90	+$8.74M → CYYNF
4	$74,364,546	$64,993,317.91	$16,238	$766.49	+$74.35M → CYYNF
5	$595,318,755	$515,748,691.06	$18,179	$804.47	+$595.30M → CYYNF
6	$4,495,664,203	$3,858,673,134.79	$20,293	$841.71	+$4495.64M → CYYNF
7	$32,043,550,537	$27,233,189,840.42	$22,591	$878.14	+$32043.53M → CYYNF
8	$215,696,715,677	$181,410,116,602.38	$25,087	$913.65	+$215696.69M → CYYNF
9	$1,372,045,052,584	$1,141,249,566,809.58	$27,791	$948.18	+$1372045.02M → CYYNF
10	$8,252,648,210,323	$6,784,560,004,057.53	$30,718	$981.68	+$8252648.18M → CYYNF

CYYNF vs DIVO: Complete Analysis 2026

CYYNF — Stock

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops CYP-004, which is in Phase III clinical trial used for the treatment of osteoarthritis; and CYP-006TK, a novel polymercoated silicon wound dressing for diabetic wounds. In addition, the company develops products for the treatment of asthma, heart attack, coronary artery disease, acute respiratory distress syndrome, brain cancer, sepsis, critical limb ischemia, idiopathic pulmonary fibrosis, and renal transplantation. Cynata Therapeutics Limited has a strategic partnership with Fujifilm to provide clinical and commercial manufacturing services for, and supply of, Cynata's Cymerus therapeutic mesenchymal stem cell products. The company was formerly known as Eco Quest Limited and changed its name to Cynata Therapeutics Limited in October 2013. Cynata Therapeutics Limited was incorporated in 2003 and is based in Cremorne, Australia.

Full CYYNF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this CYYNF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYYNF vs SCHD CYYNF vs JEPI CYYNF vs O CYYNF vs KO CYYNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.